Aoxing Pharmaceutical Company Inc (PK) News - AOXG | ADVFN

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
USOTC
Aoxing Pharmaceutical Company Inc (PK) (AOXG)
Aoxing Pharmaceutical Company Inc (PK) (AOXG) News

Aoxing Pharmaceutical Company Inc (PK) (AOXG)

0.0053

0.00

(0.00%)

Closed August 09 4:00PM

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

TransCode Therapeutics, Inc. Announces Closing of Public Offering

BOSTON, July 24, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the...

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

TransCode Therapeutics, Inc. Announces Pricing of Public Offering

BOSTON, July 22, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (“TransCode” or the...

Form 424B5 - Prospectus [Rule 424(b)(5)]

TransCode Therapeutics, Inc. Announces Proposed Public Offering of Common Stock

BOSTON, July 22, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K/A - Current report: [Amend]

Form 8-K - Current report

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements

BOSTON, June 10, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (the “Company”), an...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

1
Next

jammy32

jammy32 2 minutes ago

Hopefully we get some new soon. Best of luck to all

Monksdream

Monksdream 4 minutes ago

PGY reported
https://investorshub.advfn.com/uimage/uploads/2024/8/9/hy[dxIMG_0367.gif

ham n slam

ham n slam 4 minutes ago

still holding 4 mil shares..so i hear ya....man at this point i wish theyd do a deal with anyone..buyout is a long shot...an inch of good news will make it move and then too where nobody knows...a simple pr would do something...but dont bet on that either.

nelson1234

nelson1234 4 minutes ago

AATC looks like another solid quarter

uranium-pinto-beans

uranium-pinto-beans 5 minutes ago

CyberArk price target raised to $315 from $295 at Baird
Baird raised the firm's price target on CyberArk to $315 from $295 and keeps an Outperform rating on the shares. The firm said they delivered a standout Q2, exceeding expectations and raising full-year guidance across all metrics.

TheRealMrPirate

TheRealMrPirate 5 minutes ago

"To wait for it".
To wait for what? 🤣
#bioa-Q is FKA for a reason.

uranium-pinto-beans

uranium-pinto-beans 5 minutes ago

Decreases in stock option open interest $AMZN $NVDA $BMBL $TSLA $INTC $MMM $SIRI

TRAPPER JIM

TRAPPER JIM 6 minutes ago

Super excited to see it finally being built

StayHumble

StayHumble 6 minutes ago

No R/S+$5M Buyback+$HCWC+Dividend+Institutionalinvestors

-A buyback of up to $5,000,000 of $HCMC common stock.

-A spinoff of certain HCMC assets into a new publicly traded company (hereinafter referred to as “NewCo” until a name is announced).

-A stock di

TRAPPER JIM

TRAPPER JIM 6 minutes ago

Better late than never lol

StayHumble

StayHumble 7 minutes ago

Full Year Sales $55M+Up90%|GrossProfit $20M+Up 99%;over 2022 ✅
https://www.healthiercmc.com/news/240327-hcmc-q4-2023-results
https://img.wattpad.com/3063c9cd99bde22340df84491c00af9aafb107a5/68747470733a2f2f73332e616d617a6f6e6177732e636f6d2f776174747061642d6d656469612d736572766963652f53

MDA

MDA 7 minutes ago

I haven't seen anything, I don't even know if the CEO is still alive or capable of running his company.

My guess is it will be bought and will be a share selling scam or get delisted.

1vman

1vman 8 minutes ago

***** Exactly ! its in the filings for all to see -- NRDE ( Pu ride )

The $170 Million was not for the plant, it was the joint venture investment agreement .

ENOUGH SAID

nelson1234

nelson1234 8 minutes ago

new highs for you? I didn't make new highs.

mrkirby

mrkirby 8 minutes ago

Wow! Another snarky post by a basher. Bashers have no substance to post about anymore. Their house of cards is caving in.

Golden Cross

Golden Cross 9 minutes ago

$LPSN Undervalued: $142.2M Cash on Hand ~ $1.65 Cash/Share!

Semperfiguy

Semperfiguy 9 minutes ago

Believe it or not I am still holding some here. I too figured that Ahole didn't go through all of that for nothing.

DarkPool

DarkPool 9 minutes ago

Putin Signs Law Legalizing Cryptocurrency Mining In Russia. Looks like those machines are being turned in not off:) crypto is our future period!
.

ZRock

ZRock 10 minutes ago

good question, wish I knew the answer!

imo, there's a lot of games going on with KSCP trading

Golden Cross

Golden Cross 10 minutes ago

$LPSN Undervalued: $142.2M Cash on Hand ~ $1.65 Cash/Share!

Hosai

Hosai 10 minutes ago

You still are yet to explain how they should have presented the results with the pre-specified end point of 48 weeks for participants who dropped out for example in week 6. You seem to be saying they should magically be part of the pre-specified week 48 analysis and Anavex should just guess where th

JRoon71

JRoon71 11 minutes ago

Seminole Red

Seminole Red 14 minutes ago

R1 will begin at 9:50 a.m. ET, Friday.

Zadie420

Zadie420 16 minutes ago

No He is not. He just stated the obvious. Merck - K works only on a sub-group of cancer patients. Many, many trials using combo have failed. They could have partner with NWBO but because of greed they chose otherwise. To be honest with you they might be the one suppressing the NWBO PPS at this time

Aoxing Pharmaceutical (PK)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions